Michael S. Ip

9.2k citations
183 papers · 7.1k · 4 hit papers · h-index 44

Impact in

  • Ophthalmology top 0.05%
    • Retinal Diseases and Treatments
    • Retinal and Optic Conditions
    • Glaucoma and retinal disorders
    • Ocular Diseases and Behçet’s Syndrome
    • Intraocular Surgery and Lenses
    • Retinal Imaging and Analysis
    • Retinal and Macular Surgery

Papers in

    • Retinal Diseases and Treatments 123
    • Retinal and Optic Conditions 31
    • Glaucoma and retinal disorders 8
    • Ocular Diseases and Behçet’s Syndrome 5
    • Retinal Imaging and Analysis 22
    • Retinal and Macular Surgery 17

Michael S. Ip

175 papers receiving 6.7k citations

Michael S. Ip's Hit Papers

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials 2023 · 305 citations
3050+5+11Years since publication100200300400500

Peers

Michael S. Ip
Comparison fields: 5 of 106
  • Ophthalmology 5.3k
  • Radiology, Nuclear Medicine and Imaging 2.3k
  • Molecular Biology 961
  • Clinical Biochemistry 77
  • Neurology 80
Replace Nancy Holekamp with:
Nancy Holekamp United States
Monika Fleckenstein Germany
Jeeyun Ahn South Korea
José García‐Arumí Spain
IRENE A. BARBAZETTO United States
Jaclyn Lekse Kovach United States
Christina J. Flaxel United States
Armin Wolf Germany
Giuseppe Querques Italy
Philip G. Hykin United Kingdom
Michael S. Ip relative to Nancy Holekamp United States Nancy Holekamp's profile →
Citations per field
00.5×1.5×2.0×
Nancy Holekamp · 1×
Citations per year

Countries citing papers authored by Michael S. Ip

Since Specialization
Citations

This map shows the geographic impact of Michael S. Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Ip more than expected).

Fields of papers citing papers by Michael S. Ip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Ip. The network helps show where Michael S. Ip may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael S. Ip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael S. Ip Line = papers co-authored together Michael S. Ip links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
Hit paper breakdown →
2009569
2
Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
Hit paper breakdown →
2010452
3 2002317
4
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Hit paper breakdown →
2023305
5 1999230
6
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
Hit paper breakdown →
2023218
7 2012215
8 2017178
9 2011168
10 2018167
11 2004161
12 2014158
13 2010127
14 2008123
15 2018111
16 2009108
17 200299
18 201998
19 200796
20 201888

About Michael S. Ip

Michael S. Ip is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Neurology and Clinical Biochemistry, having authored 183 papers that have together received 7.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (123 papers), Retinal and Optic Conditions (31 papers), Retinal Imaging and Analysis (22 papers), Retinal and Macular Surgery (17 papers), Retinal Development and Disorders (14 papers), Glaucoma and retinal disorders (8 papers), Ocular Diseases and Behçet’s Syndrome (5 papers) and Cerebral Venous Sinus Thrombosis (3 papers). The work is most often cited by research in Ophthalmology (5.3k citations), Radiology, Nuclear Medicine and Imaging (2.3k citations), Molecular Biology (961 citations), Clinical Biochemistry (77 citations) and Neurology (80 citations). Michael S. Ip has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Ingrid Ursula Scott, Barbara A. Blodi, Paul VanVeldhuisen, Neal L. Oden, Andrew M Hendrick, Jason S. Ehrlich, Amitha Domalpally, Clement K. Chan, Michael John Tolentino and Srinivas Reddy Sadda. Their work appears in journals such as Ophthalmology, American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science, Retina and JAMA Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact